#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paget's disease of the vulva Testicular leiomyosarcoma Atopic keratoconjunctivitis Adenocarcinoma gastric Neonatal asphyxia Stevens-Johnson syndrome Alveolar proteinosis Chronic graft versus host disease in skin Alpha-1 antitrypsin deficiency Fontan procedure Bile acid synthesis disorder Acute graft versus host disease Primary myelofibrosis Primary biliary cholangitis Chronic cutaneous lupus erythematosus More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis – Basic Information IgA nephropathy – Life with Disease Glomerulonephritis membranoproliferative – Diagnostics Prader-Willi syndrome – Life with Disease Sarcoma – Life with Disease Propionic acidaemia – Treatment Antithrombin III deficiency Richter’s syndrome – Trials in Disease Primary biliary cholangitis – Diagnostics Pituitary-dependent Cushing’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Astegolimab Diclofenac Diethylamine 4-Hydroxy-N-Desmethyltamoxifen Maribavir A/H1N1 INFLUENZA VACCINE Glofitamab Valiltramiprosate Cisatracurium Besilate Daplusiran Levofloxacin AZD5148 Acp-204 Tartrate Emapalumab Basiliximab Cetrorelix Riboflavin Sodium Phosphate Valbenazine Ditosylate Fostemsavir Trometamol TALADEGIB Atrasentan Hydrochloride More therapies…

    Learn about Your Condition

    Chorioretinitis Retinal vein occlusion Piriformis syndrome Pouchitis Prostatitis Escherichia coli Wolfram syndrome Malignant melanoma Enteritis Complicated appendicitis Immune thrombocytopenia Friedreich's ataxia Patent ductus arteriosus Varicella Lennox-Gastaut syndrome Proteus syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Laiko General Hospital Of Athens

Laiko General Hospital Of Athens

Messogion Avenue 152, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Abatacept
    Cyprus Denmark France Germany Greece Ireland +3

  • Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Adalimumab
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +5

  • Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia Estonia France Germany +10

  • Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Thrombolysis
    Investigated Drugs:
    • Bay 3018250
    Belgium Bulgaria Czechia France Germany Greece +5

  • Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Capecitabine
    • Doxorubicin
    • Doxorubicin Hydrochloride, Liposomal
    Austria France Germany Greece Hungary Ireland +7

  • Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Aprepitant
    • Netupitant
    • Ondansetron
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Zipalertinib
    • Carboplatin
    • Cisplatin
    Belgium Bulgaria France Germany Greece Italy +4

  • Study on the Safety and Effectiveness of Telisotuzumab Vedotin for Patients with Previously Treated c-Met Positive Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Telisotuzumab Vedotin
    Belgium France Germany Greece Ireland Italy +2

  • Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • Olaparib
    • Carboplatin
    • Cisplatin
    Belgium Bulgaria Estonia France Greece Hungary +5

  • Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic hepatitis B
    • Hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3
Previous Page
1 … 32 33 34 35 36 … 38
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!